Hematology

Test Name	Used For	Specimen Type	Container/Tube	Report Availability	Specimen Retention Time
Complete Blood Count	Screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy or systemic disease.	Whole blood	Puple top EDTA	Apprx. 2 Hrs / same day	7 days
Peripheral Smear	Screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy or systemic disease.	Whole blood	Puple top EDTA	Apprx. 2 Hrs / same day	7 days
Bone Marrow Biopsy And Reporting	Diagnosis of blood diseases that originate in the bone marrow or non-blood diseases in other tissues that may have spread to the bone marrow via the blood stream. This includes but is not limited to infections, various types of blood cancers, bone marrow metastasis from a solid organ tumor. This test is also used to assess the effect of cancer treatment on bone marrow.	Whole blood	Puple top EDTA / Heparin/Green top	BM Aspirate; 3 days, BM Biopsy; 5 days.	All samples will be retained for 48 hours, Morphology and Flow Samples in 4 deg C, Cytogenetics at Room Temperature.
HB Electrophorosis	Screening and Clinical Diagnosis of Hemoglonopathies, Thalassemia syndromes and Hb Variants	Whole blood	Puple top EDTA	Apprx. 2 Hrs / same day	7 days
HB Electrophorosis	Screening and Clinical Diagnosis of Hemoglonopathies, Thalassemia syndromes and Hb Variants	Whole blood	Puple top EDTA	Apprx. 2 Hrs / same day	7 days
Peripheral Smear	Screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy or systemic disease.	Whole blood	Puple top EDTA	Apprx. 2 Hrs / same day	7 days
Bone marrow biopsy and reporting	Diagnosis of blood diseases that originate in the bone marrow or non-blood diseases in other tissues that may have spread to the bone marrow via the blood stream. This includes but is not limited to infections, various types of blood cancers, bone marrow metastasis from a solid organ tumor. This test is also used to assess the effect of cancer treatment on bone marrow.	Whole blood	Puple top EDTA / Heparin/Green top	BM Aspirate; 3 days, BM Biopsy; 5 days.	All samples will be retained for 48 hours, Morphology and Flow Samples in 4 deg C, Cytogenetics at Room Temperature.
Complete Blood Count	Screening tool to confirm a hematologic disorder, to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy or systemic disease.	Whole blood	Puple top EDTA	Apprx. 2 Hrs / same day	7 days
ESR	Screening for Presence of Inflammation, Monitoring of response to anti-inflammatory or anti-infection therapy.	Whole blood	Puple top EDTA	2 hours	24 hours
PT	Monitoring & Dose Adjustment for Warfarin Therapy, Liver Function Assessment, In combination with Activated Partial Thromboplastin Time(aPTT) and/or Bleeding Time to assess coagulation status.	Whole blood	3.2% Tri-Sodium Citrate Tube with Blue Top	2 hours	24 hours
APTT	Monitoring & Dose Adjustment for Warfarin Therapy, Liver Function Assessment, In combination with Activated Partial Thromboplastin Time(aPTT) and/or Bleeding Time to assess coagulation status.	Whole blood	3.2% Tri-Sodium Citrate Tube with Blue Top	2 hours	24 hours
RBC Osmotic Fragility	Manual, Exposure of an RBC Suspension to increasingly dilute normal saline solutions and measuring percent hemolysis	Whole blood	Purple Top	12 hours	24 hours
G6PD Qualitative	Screening assessment of G6PD or Glucose 6 Phosphate Dehydrogenase enzyme in sample Red Cells.	Whole blood	Puple top EDTA	Apprx. 2 Hrs / same day	24 hours